Humalog Mixture is the latest innovation in diabetes care

Eli Lilly brings a first of its kind insulin mixture that caters specifically to the Indian patient.

Mumbai

Eli Lilly has unveiled its latest innovation in the area of diabetes care called 'Humalog Mix', the world's first insulin analog mixtures. It offers people with diabetes convenience, control and flexibility. It absorbs quickly and starts working within minutes to lower blood sugar. Humalog is the first mealtime insulin and is available at Rs 389 per cartridge.

It is available in three different variations Humalog insulin lispro (rDNA origin), Humalog Mix 25 and Humalog Mix 50. These analog insulins are used as part of total glucose management. Humalog Mixtures provides both fasting and postprandial control and can help in preventing short term and long term complications.

Humalog Mix25 and Humalog Mix50 meet a number of patient and physician needs. Mix 50 is particularly in accord with the unpredictable eating pattern of Indian patients. The new drugs provide the convenience and mixing accuracy of pre-mixed insulins with the benefits of the unique rapid action of Humalog. Both are more physiological than human insulin mixtures and also improve postprandial blood glucose and control and reduce glycemic excursions.

Speaking on the occasion, Mr Rajiv Gulati, Chairman and Managing Director, Eli Lilly India, said "The challenge in diabetic care is to add quality to the patient's lives, giving them freedom of dose administration and minimize hassles in the therapy. With Humalog we aim to meet and overcome these challenges. Future would see more and more innovation in the area drug administration, formulations all aimed at improving patients lives and we at Lilly would endeavor to be the first ones to bring these to Indian public."

Eli Lilly has been at the forefront of diabetes care. It was the first company to make its products accessible to the masses by bringing down the prices of Insulin at par with animal insulin.